Saqib Islam, J.D., is a member of Silverback Therapeutics’ board of directors. He is currently chief executive officer and director of SpringWorks Therapeutics, a clinical-stage company developing medicines for underserved patient populations. Previously, Mr. Islam was chief business officer of Moderna, and executive vice president and chief strategy officer of Alexion Pharmaceuticals. Prior to joining the biotechnology industry, he worked for over 25 years in international business management, having held leadership positions in the healthcare investment banking divisions of Morgan Stanley and Credit Suisse Securities, and also having worked as a management consultant at The Boston Consulting Group. He holds a J.D. from Columbia Law School.